Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From SKion GmbH

Roche Could Have The Best Obesity Pill

That is, if very early data in a handful of patients are borne out in later, larger studies.

Companies Metabolic Disorders

Akero Shows More Strong Fibrosis Data, But Analysts Cite Safety Worry

Akero is developing weekly injectable efruxifermin for MASH with solid 96-week efficacy data and three Phase III studies underway. But will it find a treatment niche in a competitive space?

Business Strategies Clinical Trials

Boehringer Backs Up Best-In-Class MASH Claims With Fibrosis Data

Survodutide burnishes its best-in-class MASH case with a 64% improvement in moderate-to advanced fibrosis at Phase II, but tolerability an issue

Clinical Trials Metabolic Disorders

EASL: Tirzepatide Is The One To Beat In MASH

An important mid-stage trial succeeds, but an odd finding on the fibrosis endpoint will spur close examination of Lilly’s incretin.

Clinical Trials Metabolic Disorders
See All

Company Information

  • Industry
  • Miscellaneous
  • Other Names / Subsidiaries
    • Altana AG
UsernamePublicRestriction

Register